Altamira Therapeutics Ltd. Quarterly Liabilities in CHF from Q4 2016 to Q4 2023

Taxonomy & unit
ifrs-full: CHF
Summary
Altamira Therapeutics Ltd. quarterly Liabilities history and growth rate from Q4 2016 to Q4 2023.
  • Altamira Therapeutics Ltd. Liabilities for the quarter ending December 31, 2023 was ₣1.24M, a 91.5% decline year-over-year.
Liabilities, Quarterly (CHF)
Liabilities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 1.24M -13.4M -91.5% Dec 31, 2023 20-F/A 2024-04-22
Q2 2023 8.03M -3.71M -31.6% Jun 30, 2023 6-K 2023-09-12
Q4 2022 14.6M +8.48M +138% Dec 31, 2022 20-F/A 2024-04-22
Q2 2022 11.7M +8.09M +222% Jun 30, 2022 6-K/A 2023-08-21
Q4 2021 6.13M +2.1M +52.2% Dec 31, 2021 6-K/A 2023-08-21
Q2 2021 3.65M +163K +4.69% Jun 30, 2021 6-K 2021-09-08
Q4 2020 4.03M +839K +26.3% Dec 31, 2020 20-F 2022-04-12
Q2 2020 3.49M +704K +25.3% Jun 30, 2020 6-K/A 2020-09-17
Q4 2019 3.19M -3.04M -48.8% Dec 31, 2019 20-F 2021-03-31
Q2 2019 2.78M Jun 30, 2019 6-K 2019-08-15
Q4 2018 6.23M -13.8M -68.8% Dec 31, 2018 20-F 2020-04-16
Q4 2017 20M -1.53M -7.1% Dec 31, 2017 20-F 2019-03-14
Q4 2016 21.5M Dec 31, 2016 20-F 2018-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.